» Articles » PMID: 36945935

Investigation of Taurine and Aqueous Garlic Extract Diet Supplementation Effect on the Healing of Rat Osteoporotic Fractures

Abstract

Background: We have evaluated the effects of taurine and aqueous garlic extract (AGE) as a dietary supplement on osteoporotic fracture (OPF) healing in the ovariectomized rat femur fracture model.

Methods: In this experimental animal study,twenty-four osteoporosis-remodeled female Wistar albino rats were randomly divided into 3 groups (n: 8) according to their supplemented diet; control, taurine, and AGE groups. Unilateral femur middiaphysis mini-open osteotomy was stabilized with Kirschner wires. Six weeks after osteotomy, the rats were sacrificed before the femurs were harvested and OPF healing was evaluated with biochemical, histologic, microcomputed-tomography, and scintigraphic methods.

Results: As an indicator of the antiosteoporotic effect, the calcium levels of the taurine group were significantly lower than the AGE and control groups in biochemical analyzes (p < 0.01). In histological studies, the new bone diameter and new bone volume values of the taurine group were significantly higher than the control group (p = 0.002 and p = 0.032, respectively), while higher trabecular-compact callus was observed in the taurine and AGE groups, respectively, compared to the control group. In morphological analyses, taurine and AGE groups had significantly higher bone volume/tissue volume, trabecular number, bone surface density, and lower trabecular separation than the control group (p < 0.05). The scintigraphic imaging showed a significant increase in osteoblastic activity of the taurine group compared to the control group (p = 0.005).

Discussion: Taurine and AGE have positive anabolic effects, respectively, on the healing of OPFs, demonstrated by biochemical, histological, morphological, and scintigraphic methods.

References
1.
Ibrahim N, Mohamad S, Mohamed N, Shuid A . Experimental fracture protocols in assessments of potential agents for osteoporotic fracture healing using rodent models. Curr Drug Targets. 2013; 14(14):1642-50. DOI: 10.2174/1389450114666131216224003. View

2.
Gupta R, Win T, Bittner S . Taurine analogues; a new class of therapeutics: retrospect and prospects. Curr Med Chem. 2005; 12(17):2021-39. DOI: 10.2174/0929867054546582. View

3.
Choi M, Chang K, Lee J, Jung Y . Beneficial Function of Taurine on Bone Metabolism in Alcohol-Fed OVX Rat Model. Adv Exp Med Biol. 2017; 975 Pt 2:1059-1069. DOI: 10.1007/978-94-024-1079-2_84. View

4.
DEufemia P, Finocchiaro R, Celli M, Raccio I, Zambrano A, Tetti M . Taurine deficiency in thalassemia major-induced osteoporosis treated with neridronate. Biomed Pharmacother. 2010; 64(4):271-4. DOI: 10.1016/j.biopha.2009.06.014. View

5.
Santic V, Zoricic Cvek S, Sestan B, Bobinac D, Tudor A, Miletic D . Treatment of tibial bone defect with rotational vascular periosteal graft in rabbits. Coll Antropol. 2009; 33(1):43-50. View